Health Care Journals | Open Access - Edelweiss | Edelweiss Publications

Edelweiss Journal of Biomedical Research and Review (ISSN 2690-2613)

Case Report

Improved Hypertension by Investigating Circadian Rhythm of Blood Pressure

Tadao Shimamura, Hiroshi Bando, Shinji Nagahiro, Miwako Nakanishi and Osami Watanabe

DOI Number:


Published on January, 2021


Case: The case is 86-year-old male hypertensive patient with anti-hypertensive drug for 5 years. He has been provided Amlodipine besilate 5mg at 0800h and doxazosin mesylate 2mg at 2300h for long. In June 2020, he noticed unstable fluctuation of Blood Pressure (BP) during morning, afternoon and night. Results: Then, he checked the circadian rhythm of BP, which showed higher BP in early morning, decreasing BP 0800-1000h, minimum BP during 1000-1400h, increasing BP during 1400-1800h and stable BP during 1800-2400h. Due to the result, he changed to take amlodipine at 2300h. Consequently, his BP gradually became stable during 24 hours after 2 weeks. Discussion: Some factors may exist for contributing improved BP fluctuation. They include a) pathophysiological characteristics of BP circadian rhythm, b) effective time for anti-hypertensive drug, c) accuracy of the obtained BP data and d) the social and psychological reliability of the patient. Regarding d) he was engaged in research and development work as a senior researcher at a chemical company. He has been also a member of New Elderly Association (NEA), which was established by Shigeaki Hinohara. He lives on the philosophy of Hinohara-ism for long, associated with stable mind and body.



Concerning the standard guideline of hypertension, there was practice guidelines for the management of hypertension for adults by the International Society of Hypertension (ISH) in 2020. The 2020 ISH guidelines have been closer to the 2018 2018 European Society of Cardiology/European Society of Hypertension (ESC/ESH) guidelines, and they include hypertension prevalence, treatment, and cardio metabolic goals. Historically speaking, hypertension has been one of the most important common diseases, and many hypertensive patients should be dealth with properly in the world. Therefore, several guidelines have been announced in European countries, North America and Japan related with hypertension and heart disease. Furthermore, several guidelines were for older and younger people, patients with obesity and lipids problems. Consequently, treatment of hypertension will require comprehensive and integrative use of each guideline for managements [1-7].


As to physiological parameters such as BP and heart rate, autonomic nervous system has influenced variability signals for cardiovascular system. It has been known that hypertension is a crucial risk factor for cardiovascular disease mortality and its therapeutic management with decreasing cardiovascular complications. Subjects (n=628) with normal and hypertensive patients were analyzed for circadian rhythms of BP. As a result, two groups showed similar tendency [8-10].


Their Systolic BP (SBP), Diastolic BP (DBP) and mean BP decrease during 0930-1500, increase during 1500-1930, have rather deeper reduction during 1930-0200 at night time and morning increase during 0530-0930. From the guideline for ABPM by ESH (European society of Hypertension) position Paper, hypertensive patients with nocturnal rise show poor tendency for cardiovascular prognosis. Similarly, rising pattern at night have higher risk of cardiovascular events. Furthermore, recent review showed that nocturnal rising suggests powerful marker for cardiovascular poor prognosis associated with adjusting for other risk factors [10-13].


Thus, it would be important to examine and deal with the circadian rhythm of blood pressure for the treatment and management of hypertension. Through our medical practice experiences, there was an impressive elderly male patient with hypertension. He showed initially unstable circadian rhythm of BP, but afterwards stable and lower BP after changed time of medication. In this article, general clinical course will be presented associated with some discussion.

 Case Report


History of Present Illness

The case is 86-year-old male patient with hypertension, Type 2 Diabetes Mellitus (T2DM), Coronary Heart Disease (CHD) and hyperuricemia. His general status has been almost stable for more than 5 years. In May 2020, he received general physical examination and laboratory biochemical examination. He has not shown particular complaints such as diabetic symptoms, dyspnea or nocturnal breathing. He has not smoked or drinks alcohol for years.


Social history

He worked as a chemical engineer for long years. His company was Toho Rayon Company and Shikoku Kasei Chemical Corporation. He has made various achievements such as obtaining 20 patents in his daily work. He has been working as a chemical engineer, and did not have any special environmental exposure with some possible toxic agents. He has been also a member of New Elderly Association (NEA), which was established by Shigeaki Hinohara, a supreme physician with active achievements until the age of 105. He has understood and practiced Hinohara-ism every day, enjoying ballroom dancing, karaoke and ground golf, associated with stable mind and body. Such a social and psychological background exists in his regular life [14].


Physical examination

He showed no remarkable condition in physical examination and also no remarkable specific abnormalities on symptoms or signs related to hypertension, diabetes and other diseased states. His vital signs were within normal limits and he showed unremarkable physical symptoms concerning hypertension, diabetes, CHD and hyperuricemia. He showed no particular diabetic complications such as retinopathy, neuropathy or nephropathy. His Body Mass Index (BMI) was 20.4 kg/m2. He has shown no particular symptoms or signs about Chronic Kidney Disease (CKD).


Laboratory Exam

The results of laboratory exams were revealed in the following. General standard biochemical data were AST 28 U/mL (5-40), ALT 19 U/mL (5-42), r-GT 12 U/mL (7-74), BUN 28 mg/dL (8-20), Cre 1.1 mg/dL (0.5-1.0), Uric Acid 6.6 mg/dL (3.8-7.0), HDL 60 mg/dL (40-99), LDL 110 mg/dL (70-139), TG 56 mg/dL (30-149), WBC 6900 /μL (4000-8000), RBC 3.82 x 106/μL (4.2-5.4), Hb 11.3 g/dL (12.4-17.6), Plt 13.9 x 104/μL (14-34). Data related diabetes were HbA1c 6.2%, post-prandial glucose (2 hours) 180 mg/dL.



He has been given some kinds of medicine for hypertension, T2DM, coronary heart disease and hyperuricemia. The prescription includes 1) Amlodipine besilate 5mg, 2) doxazosin mesylate 2 mg, 3) Bisoprolol tape 4 mg (β1 blockade, C07AB07-ATC, D02342-Kegg), 4) Sitagliptin phosphate hydrate 50mg, 5) Febuxostat 20mg. Until May 2020, these medicines (1,4,5) were provided at 0800h after breakfast, and medicine (2,3) was provided 2300h before sleep.


Clinical progress

In June 2020, he has noticed unstable fluctuation of Blood Pressure (BP) during morning, afternoon and night. Then, he has tried to check his circadian rhythm of BP during June 1-5. After that, he measured the detail fluctuation of BP during June 16-21 and July 3-7, 2020.



The result of 24-hours measurement of BP during June 1-6 was shown in Figure 1a. There was a tendency of large difference of daily BP, associated with higher BP (150-170 mmHg) in early morning, decreasing BP (130-150 mmHg) during 0800-1000h, minimum BP (110-130 mmHg) during 1000-1400h, increasing BP tendency (120-140 mmHg) during 1400-1800h and rather stable BP (120-130 mmHg) during 1800-2400h. Due to the result of BP, he was advised to take amlodipine besilate at 2300h instead of 0800h. This changed method was started from June 16. The BP profile during June 16-21 was shown in Figure 1b. There was some changed tendency, associated with around 140 mmHg during 0400-0800h, 130-140mmHg during 0800-1400h, 120-130 mmHg during 1400-1800h and a little wider distribution during 1800-2400h. After 2 weeks, he showed stable measurements of BP profile during 24 hours (Figure 1c). They revealed about 120-130 mmHg during 0100-1000h, 110-120 mmHg during 1000-1600h, 120-130 mmHg during 1600-2300h. The data seemed to be ideal status, associated stable and flat level.




In this report, hypertensive patient with large BP difference has improved by measuring the diurnal BP fluctuations and changing the time of taking antihypertensive drugs. Several factors seem to be involved in this situation. They are the physiological and pathological characteristics of BP circadian rhythm, the length of effective time for anti-hypertensive drug, accuracy of the obtained BP data and the social and psychological reliability from the background of the patient. Some discussions are described in the following. There are three patterns for BP profiles during night time. They are dippers, non-dippers and risers or reverse dippers. These three groups were also found in several studies using home BP, Ambulatory BP Monitoring (AMPM) (ABPM) and in hospitalized older patients.


Elderly patients show riser pattern and reverse dipping patterns in common. According to the lots of data (1.7 million) of BP in England, the results of systolic and diastolic BP were shown as the same as the from outpatient populations by ABPM. For late middle age in-patients, nocturnal dipping BP changes were not clear. Instead of that, they showed rather late nocturnal BP rise, associated with higher nighttime systolic BP than the peak systolic daytime BP. This tendency was observed for the patients with and without hypertension. This circadian tendency for in-patients were not been observed so far. However, these patterns seem to be compatible with the results of ABPM in the community studies. By a systematic review, dipping at night was evaluated as a lower risk of cardiovascular events, whereas rising BP during night time seems to be associated with elevated risk [12,15-21].


Recent investigations have revealed that non-dipper patients tend to show more damage of target organs and their related complications. In the case of normal physiological states, there are several functional characteristics such as increased heart rate, blood pressure and vasospastic tone, excessive platelet aggregation and activity. Some proteins with regulatory missions or activator for platelet activity including SCUBE1 (containing the protein-1 domain containing the signal peptide-cub-egf domain) and soluble CD40 Ligand (sCD40L). Both were reported to be significantly higher in the non-dipper patients than normal subjects. After the current case changed the time to taking the antihypertensive drug, the circadian rhythm of BP was improved to stable situation. This change seemed to be involved in amlodipine administration. There was a report of pharmacokinetics and comparative bioavailability of amlodipine [22-25].


The protocol was administration of amlodipine 2.5, 5 and 10mg to 12 healthy male volunteers. The results were summarized as follows: a) diastolic BP was decreased by 1.1, 4.8 and 8 mmHg six hours in 3 doses, b) the time until the peak level was 5.6-6.4 hours, respectively, c) each half-life was 31.2, 33 and 36.8 hours, respectively. The author suggested that amlodipine would be effective once daily because of its gradual absorption and long half-life.


Considering both of the pharmacokinetics of amlodipine and actual progress of current case (Figure 1a,b,c) together, the peak time seems to be related to unstable fluctuation of BP. In our usual medical practice, many patients with hypertension have often taken anti-hypertensive drug once in the morning. In some cases, measuring diurnal BP fluctuation may contribute the screening for detecting unstable BP. Hypertension is one of life style-related disease. Concerning the standard management for hypertension, there was High Blood Pressure Clinical Practice Guideline by American College of Cardiology/American Heart Association Task Force.

Figure 1a: BP profile during June 1-4 with large BP fluctuation.

Figure 1b: Ratherfluctuation after changed timing of amlodipine from 0800h to 2300h. 

Figure 1c: Stable BP with smaller BP difference.

Figure 1: Results of circadian rhythm of blood pressure with changed timing of antihypertensive drug.

It includes six items of I-A level for recommendations for non-pharmacological interventions. They include weight control, healthy diet including DASH (Dietary Approaches to Stop Hypertension) diet, sodium reduction, supplementation of potassium, encouraging physical activity and decrease of alcohol consumption. Various factors are involved in the fluctuation of blood pressure. In this case, there is no smoking or no risk factors for dyslipidemia. Then, it would be necessary to consider the possibility of influence, such as hypertension, cardiovascular disease, smoking and sleep-respiratory disease. In particular, no obvious abnormal findings were found in this case. The patient has been originally a scientist, and his lifestyle has persisted regular and ideal situation. In addition, he has been enlightening by Hinohara-ism, and recently living along with the philosophy [4,14,26-32]. In this way, it is considered that BP has been evaluated and controlled this time due to the excellent social and psychological conditions.


In summary, an 86-year-old patient with hypertension showed unstable BP fluctuations. After measuring daily BP profile and changing taking time for anti-hypertensive drug, BP became stabilized. This course was discussed from some aspects including BP circadian rhythm, antihypertensive drugs, obtained data and the background of the patient. This report will be hopefully useful for future research and treatment of hypertension.

 Ethical Considerations


This research has been conducted in compliance with the ethical principles presented on the Declaration of Helsinki. Moreover, there was comment for the Ethical Guidelines against the Research in the medical field for Human beings and also against the conduction of the Good Clinical Practice (GCP). We have applied adequately “Ethical Guidelines for Epidemiology Research” for the related guideline. These principles were originated from Japan by the Ministry of Health, Labor and Welfare and also by the Ministry of Education, Culture, Sports, Science and Technology. For the current subject, the written informed consents from the patient.




1.        Verdecchia P, Reboldi G and Angeli F. The 2020 International Society of Hypertension global hypertension practice guidelines-key messages and clinical considerations (2020) Eur J Intern Med 82: 1-6.

2.        Gijón-Conde T, Sánchez-Martínez M, Graciani A, Cruz JJ, López-García E, et al. Impact of the European and American guidelines on hypertension prevalence, treatment, and cardiometabol ic goals (2019) J Hypertens 37: 1393-1400.

3.        Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (2012) Eur Heart J 33: 1635-1701.

4.        Whelton PK, Carey RM, Aronow WS, CaseyJr DE, Collins KJ, et al. ACC/AHA (2017) 2017 High Blood Pressure Clinical Practice Guideline. Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults, 2017.

5.        The Task Force for the management of Hypertension of the Japanese Society of Hypertension (JSH) and JSH (2014) Guideline for the management of hypertension 2014.

6.        The Japan Geriatrics Society. The Japan Geriatrics Society Guidelines for the management of elderly hypertension (2017) J Jap Geriat Soc 54: 236-237.

7.        Catapano AL, Graham I, Backer GD, Wiklund O, Chapman MJ, et al. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Association for Cardiovascular Prevention and Rehabilitation (EACPR) (2016) Atherosclerosis 253: 281-344.

8.        Johansen CD, Olsen RH, Pedersen LR, Kumarathurai P, Mouridsen MR, et al. Resting night-time and 24 h heart rate as markers of cardiovascular risk in middle aged and elderly men and women with no apparent heart disease (2013) European Heart J 34: 1732-1739.

9.        Palatini P, Saladini F, Mos L, Fania C, Mazzer A, et al. Low night-time heart rate is longitudinally associated with lower augmentation index and central systolic blood pressure in hypertension (2018) European J Appl Physiol 118: 543-550.

10.      Silveri G, Accardo A and Pascazio L. Relationship between blood pressure and heart rate circadian rhythms in normotensive and hypertensive subjects (2018) CinC 45: 1-4.

11.      OBrien E, Parati G, Stergiou G, Asmar R, Beilin L, et al. European society of hypertension position paper on ambulatory blood pressure monitoring (2013) J Hypertens 31: 1731-1768.

12.      Taylor KS, Heneghan CJ, Stevens RJ, Adams EC, Nunan D, et al. Heterogeneity of prognostic studies of 24-hour blood pressure variability: systematic review and meta-analysis (2015) PLoS One 10: 0126375.

13.      Cuspidi C, Sala C, Tadic M, Gherbesi E, De Giorgi A, et al. Clinical and prognostic significance of a reverse dipping pattern on ambulatory monitoring: an updated review (2017) J Clin Hypertens 19: 713­-721.

14.      Bando H, Yoshioka A, Iwashimizu Y, Iwashita M and Doba N. Development of Primary Care, Lifestyle Disease and New Elderly Association (NEA) in Japan-Common Philosophy With Hinohara-ism (2017) Prim Health Care 7: 281.

15.      Kario K. Nocturnal hypertension: new technology and evidence (2018) Hypertension 71: 997-1009.

16.      Yoshida T, Kuwabara M, Hoshide S and Kario K. Recurrence of stroke caused by nocturnal hypoxia-induced blood pressure surge in a young adult male with severe obstructive sleep apnea syndrome (2016) J Am Soc Hypertens 10: 201-204.

17.      Salles GF, Reboldi G, Fagard RH, Cardoso CRL, Pierdomenico SD, et al. Prognostic Effect of the Nocturnal Blood Pressure Fall in Hypertensive Patients: The Ambulatory Blood Pressure Collaboration in Patients with Hypertension (ABC-H) Meta-Analysis (2016) Hypertension 67: 693-700.

18.      Salvo F, Lonati C, Berardi M, Errani AR, Muzzulini CL, et al. Nocturnal blood pressure dipping is abolished in old-elderly hospitalized patients (2017) High Blood Press Cardiovasc Prev 24: 413-417.

19.      Su D, Guo Q, Gao Y, Han J, Yan B, et al. The relationship between red blood cell distribution width and blood pressure abnormal dipping in patients with essential hypertension: a cross-sectional study (2016) BMJ 6: 010456.

20.      Mahdi A, Watkinson P, McManus RJ and Tarassenko L. Circadian blood pressure variations computed from 1.7 million measurements in an acute hospital setting (2019) Am J Hypertens 32: 1154-1161.

21.      Yoshida T, Kuwabara M, Hoshide S and Kario K. Recurrence of stroke caused by nocturnal hypoxia-induced blood pressure surge in a young adult male with severe obstructive sleep apnea syndrome (2016) J Am Soc Hypertens 10: 201-204.

22.      Alp C, Dogru MT, Karadeniz M, Sarak T, Demir V, et al. Serum pentraxin-3 levels and flow-mediated dilation in dipper and non-dipper hypertension (2019) J Clin Lab Anal 33: 22718.

23.      Alpaydin S, Turan Y, Caliskan M, Caliskan Z, Aksu F, et al. Morning blood pressure surge is associated with carotid intima-media thickness in prehypertensive patients (2017) Blood Press Monit 22: 131-136.

24.      Guzel M, Dogru MT, Simsek V, Demir V, Alp C, et al. Influence of circadian blood pressure alterations on serum SCUBE-1 and soluble CD40 ligand levels in patients with essential hypertension (2019) Am J Cardiovasc Dis 9: 42-48.

25.      Williams DM and Cubeddu LX. Amlodipine pharmacokinetics in healthy volunteers (1988) J Clin Pharmacol 28: 990-994.

26.      Neter JE, Stam BE, Kok FJ, Grobbee DE and Geleijnse JM. Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials (2003) Hypertension 42: 878-884.

27.      Bommel EV and Cleophas T. Potassium treatment for hypertension in patients with high salt intake: a meta-analysis (2012) Int J Clin Pharmacol Ther 50: 478-482.

28.      Mozaffarian D, Fahimi S, Singh GM. Micha R, Khatibazade S, et al. Global sodium consumption and death from cardiovascular causes (2014) N Engl J Med 371: 624-634.

29.      Inder JD, Carlson DJ, Dieberg G, McFarlane JR, Hess NC, et al. Isometric exercise training for blood pressure management: a systematic review and meta-analysis to optimize benefit (2016) Hypertens Res 39: 88-94.

30.      Roerecke M, Kaczorowski J, Tobe SW, Gmel G, Hasan O, et al. The effect of a reduction in alcohol consumption on blood pressure: a systematic review and meta-analysis (2017) Lancet Public Health 2: 108-120.

31.      Pezzuto A and Carico E. Effectiveness of smoking cessation in smokers with COPD and nocturnal oxygen desaturation: Functional analysis (2019) Clin Respir J 14: 29-34.

32.      Bando H, Yoshioka A and Nishikiori Y. Medicine and philosophy with supreme humanity and achievement by great physicians, Schweitzer, Osler and Hinohara (2020) Int J Fam Commun Med 4: 74-76.


*Corresponding author

 Hiroshi Bando, Tokushima University/Medical Resea, Nakashowa 1-61, Tokushima 770-0943, Japan 

Tel: +81-90-3187-2485, E-mail:


Shimamura T, Bando H, Nagahiro S, Nakanishi M and Watanabe O. Improved hypertension by investigating circadian rhythm of blood pressure (2021) Edel J Biomed Res Rev 3: 1-4.


Hypertension, Circadian Rhythm of Blood Pressure, Antihypertensive drug, Amlodipine besilate, Hinohara-ism.